CLCNKB Gene Bartter Syndrome Type 3 Genetic Test
Introduction
The CLCNKB Gene Bartter Syndrome Type 3 Genetic Test offered by DNA Labs UAE is a comprehensive genetic test that analyzes the CLCNKB gene to identify mutations associated with Bartter syndrome type 3. This rare genetic disorder affects the kidneys’ ability to reabsorb salt and maintain electrolyte balance.
Test Details
The CLCNKB gene is responsible for producing a protein called chloride channel, voltage-sensitive Kb. This protein plays a crucial role in maintaining the balance of chloride ions in the kidneys. Mutations in the CLCNKB gene can lead to Bartter syndrome type 3.
Symptoms and Diagnosis
Bartter syndrome type 3 is characterized by various symptoms related to electrolyte imbalances, such as excessive urination, dehydration, muscle weakness, and growth delays. Diagnosis of Bartter syndrome type 3 involves genetic testing, specifically NGS (Next-Generation Sequencing) technology, which can analyze multiple genes simultaneously to identify CLCNKB gene mutations.
Test Components and Price
- Test Name: CLCNKB Gene Bartter Syndrome Type 3 Genetic Test
- Components: Blood or Extracted DNA or One drop Blood on FTA Card
- Price: 4400.0 AED
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Hepatology, Nephrology, Endocrinology Disorders
- Doctor: General Physician
- Test Department: Genetics
Pre Test Information
Prior to undergoing the CLCNKB Gene Bartter Syndrome Type 3 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by Bartter syndrome type 3 and the CLCNKB gene mutation.
Importance of Genetic Testing
NGS genetic testing plays a crucial role in diagnosing Bartter syndrome type 3 and providing valuable information for the management and treatment of the condition. It can also be used for carrier testing and family planning purposes. However, it is essential that genetic testing is performed and interpreted by qualified healthcare professionals, such as geneticists or genetic counselors, who can provide appropriate counseling and guidance based on the results.
Conclusion
The CLCNKB Gene Bartter Syndrome Type 3 Genetic Test offered by DNA Labs UAE is a comprehensive and reliable genetic test that can help diagnose Bartter syndrome type 3 and provide valuable insights for the management and treatment of the condition. By identifying mutations in the CLCNKB gene, this test plays a crucial role in improving patient outcomes and facilitating informed decision-making for family planning.
Test Name | CLCNKB Gene Bartter syndrome type 3 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Hepatology Nephrology Endocrinology Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for CLCNKB Gene Bartter syndrome type 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CLCNKB Gene Bartter syndrome type 3 NGS Genetic DNA Test gene CLCNKB |
Test Details |
The CLCNKB gene is responsible for producing a protein called chloride channel, voltage-sensitive Kb, which is involved in maintaining the balance of chloride ions in the kidneys. Mutations in the CLCNKB gene can lead to a condition called Bartter syndrome type 3. Bartter syndrome is a rare genetic disorder that affects the kidneys’ ability to reabsorb salt and maintain the body’s electrolyte balance. There are several types of Bartter syndrome, and type 3 is caused by mutations in the CLCNKB gene. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that can analyze multiple genes simultaneously to identify mutations or variations that may be associated with a particular condition. In the case of Bartter syndrome type 3, NGS genetic testing can be used to identify mutations in the CLCNKB gene. By identifying specific mutations in the CLCNKB gene, NGS genetic testing can help diagnose Bartter syndrome type 3 and provide valuable information for the management and treatment of the condition. It can also be used for carrier testing and family planning purposes. It is important to note that genetic testing should always be performed and interpreted by qualified healthcare professionals, such as geneticists or genetic counselors, who can provide appropriate counseling and guidance based on the results. |